|
№
|
Name of the service
|
Unit
|
Price KZT
|
| Allergy diagnostics |
| CDL - Allergens domestic/molecular (А) |
| 70 | СDL - Domestic/molecular allergens (A) | 1 test | 4 000 |
| 71 | СDL - Fungal allergens (D) | 1 test | 4 000 |
| 72 | СDL - Tree allergens (T) | 1 test | 4 000 |
| 73 | СDL - Domestic dust allergens (H) | 1 test | 4 000 |
| 74 | СDL - Animal allergens (E) | 1 test | 4 000 |
| 75 | СDL - Inhalant allergens (IP) | 1 test | 4 000 |
| 76 | СDL - Drug allergens © | 1 test | 4 000 |
| 77 | СDL - Insect allergens (I) | 1 test | 4 000 |
| 78 | СDL - Parasitic allergens (P) | 1 test | 4 000 |
| 79 | СDL - Food-based allergens (F) | 1 test | 4 000 |
| 80 | СDL - Musty allergens (M) | 1 test | 4 000 |
| 81 | СDL - Professional allergens (K) | 1 test | 4 000 |
| 82 | СDL - Other allergens (O) | 1 test | 4 000 |
| 83 | СDL - Weed allergens (W) | 1 test | 4 000 |
| 84 | СDL - Allergens of grasses and grains (G) | 1 test | 4 000 |
| Biochemical screens |
| Biochemical blood tests. Protein metabolism |
| 85 | Albumen | 1 test | 1 400 |
| 86 | Bence Jones protein in urine | 1 test | 34 210 |
| 87 | Protein immunotyping (M-gradient) | 1 test | 30 000 |
| 88 | Creatinine | 1 test | 1 500 |
| 89 | Uric acid | 1 test | 1 500 |
| 90 | Urea | 1 test | 1 500 |
| 91 | Total protein | 1 test | 1 500 |
| 92 | Blood protein electrophoresis (Protein fractions) | 1 test | 5 500 |
| Biochemical blood tests. Iron metabolism |
| 93 | Transferrin | 1 test | 2 600 |
| 94 | Ferritin | 1 test | 3 500 |
| 95 | Total Iron-Binding Capacity (TIBS) | 1 test | 3 200 |
| Biochemical blood tests. Lipoprotein metabolism |
| 96 | Apolipoprotein A (Apo-A) | 1 test | 3 300 |
| 97 | Apolipoprotein B (Apo-B) | 1 test | 3 800 |
| 98 | High density lipoproteins (HDL) | 1 test | 2 200 |
| 99 | Low-density lipoproteins (LDL) | 1 test | 1 800 |
| 100 | Triglycerides (TG) | 1 test | 1 500 |
| 101 | Cholesterol (CS) | 1 test | 1 500 |
| Biochemical blood tests. Pigment metabolism |
| 102 | Total bilirubin | 1 test | 1 700 |
| 103 | Conjugated bilirubin | 1 test | 1 700 |
| Biochemical blood tests. Carbohydrate metabolism |
| 104 | Glycosylated hemoglobin (Hemoglobin A1c, HbA1c) | 1 test | 3 500 |
| 105 | Glucose | 1 test | 1 600 |
| 106 | Glucose on the glucometer | 1 test | 400 |
| Biochemical blood tests. Enzymes |
| 107 | Alanine aminotransferase (ALT) | 1 test | 1 800 |
| 108 | Alpha amylase | 1 test | 1 900 |
| 109 | Pancreatic amylase | 1 test | 3 300 |
| 110 | Aspartate aminotransferase (AST) | 1 test | 1 800 |
| 111 | Gamma glutamyl transferase (GGTP) | 1 test | 2 400 |
| 112 | Creatinine kinase-MB fraction (CFK-MB) | 1 test | 2 500 |
| 113 | Creatine phosphokinase (CPK) | 1 test | 1 800 |
| 114 | Lactate dehydrogenase (LDH) | 1 test | 2 000 |
| 115 | Alkaline phosphatase (ALP) | 1 test | 1 700 |
| 116 | Lipase | 1 test | 2 500 |
| Biochemical urine tests |
| 117 | Glucose in a single urine portion | 1 test | 1 350 |
| 118 | Glucose in daily urine | 1 test | 1 450 |
| 119 | Urine Ca++ | 1 test | 1 400 |
| 120 | Urine creatinine | 1 test | 1 200 |
| 121 | Urine Mg++ | 1 test | 1 200 |
| 122 | Urine uric acid | 1 test | 1 200 |
| 123 | Urine urea | 1 test | 1 300 |
| 124 | Microalbumin complex (Creatinine/albumin ratio) | 1 test | 8 300 |
| 125 | Relative indices of metabolic disorders (ratio calcium/creatinine, magnesium/creatinine, inorganic phosphorus/creatinine, uric acid/creatinine | 1 test | 4 100 |
| 126 | Relative index of metabolic disorders (calcium/creatinine ratio) | 1 test | 2 900 |
| 127 | Relative index of metabolic disorders (magnesium/creatinine ratio) | 1 test | 3 100 |
| 128 | Relative index of metabolic disorders (inorganic uric acid/creatinine ratio) | 1 test | 2 700 |
| 129 | Relative index of metabolic disorders (inorganic phosphorus/creatinine ratio) | 1 test | 2 600 |
| 130 | Rehberg test | 1 test | 3 000 |
| 131 | Glomerular filtration rate | 1 test | 2 400 |
| 132 | Urine osmolarity | 1 test | 600 |
| 133 | Urine phosphorus | 1 test | 1 000 |
| 134 | Urine potassium | 1 test | 1 000 |
| 135 | Sodium urine | 1 test | 1 000 |
| 136 | Chloride urine | 1 test | 1 000 |
| Biochemistry |
| 137 | Blood osmolarity | 1 test | 1 500 |
| Immune status |
| 138 | Immunoglobulin A | 1 test | 2 400 |
| 139 | Immunoglobulin G | 1 test | 2 400 |
| 140 | Immunoglobulin M | 1 test | 2 400 |
| 141 | Complement C3 | 1 test | 3 100 |
| 142 | Complement C4 | 1 test | 2 900 |
| Hemostatic system testings |
| 143 | Thrombocyte aggregation with P2Y (PFA 200 analyzer) | 1 test | 23 300 |
| 144 | Thrombocyte aggregation with ADF (PFA 200 analyzer) | 1 test | 23 300 |
| 145 | Thrombocyte aggregation with Epinephrine (PFA 200 analyzer) | 1 test | 22 000 |
| 146 | Activated partial/batch thromboplastin time (APTT/ABTT) | 1 test | 1 500 |
| 147 | Antithrombin III (AT-3) | 1 test | 4 200 |
| 148 | Lupus anticoagulant (Lupus test) | 1 test | 6 300 |
| 149 | Duke bleeding time | 1 test | 1 000 |
| 150 | Clotting time according to Sukharev | 1 test | 1 000 |
| 151 | D-Dimer Exclusion quantification | 1 test | 8 200 |
| 152 | D-dimer (by turbidimetric immunoassay), quantification | 1 test | 10 000 |
| 153 | Coagulogram - complex No. 1 (APTT, INR, PT, PTI, fibrinogen, TT) | 1 test | 4 000 |
| 154 | Coagulogram - complex No. 2 (APTT, INR, PT, PTI, fibrinogen, TT+ SFMC) | 1 test | 5 500 |
| 155 | International normalized ratio (INR) | 1 test | 2 000 |
| 156 | Protein С | 1 test | 10 500 |
| 157 | Prothrombin time (PT) | 1 test | 1 600 |
| 158 | Prothrombin index (PTI) | 1 test | 1 600 |
| 159 | Soluble fibrin-monomer complexes (SFMC) | 1 test | 1 500 |
| 160 | C1 inhibitor | 1 test | 12 000 |
| 161 | Thrombin time (TT) | 1 test | 1 600 |
| 162 | Thromboelastogram with heparinase | 1 test | 11 700 |
| 163 | Thromboelastogram with kaolin | 1 test | 15 500 |
| 164 | Fibrinogen | 1 test | 1 500 |
| 165 | INR/PT/Quick value in capillary blood | 1 test | 8 000 |
| Specific proteins |
| 166 | Alpha - 1 - antitrypsin | 1 test | 4 800 |
| 167 | Antistreptolysin O (ASL-O) quantification | 1 test | 2 800 |
| 168 | Haptoglobin | 1 test | 1 600 |
| 169 | Myoglobin quantification | 1 test | 2 170 |
| 170 | Rheumatoid factor (RF), quantification | 1 test | 2 300 |
| 171 | C-reactive protein (CRP) quantitation | 1 test | 2 400 |
| 172 | Ceruloplasmin | 1 test | 4 080 |
| Electrolytes, mineral metabolism |
| 173 | Antibodies to TSH receptors (anti-TSHr, TSH receptor antibodies, a-rTSH) | 1 test | 8 600 |
| 174 | Ionized calcium | 1 test | 3 300 |
| 175 | Serum iron (Fe) | 1 test | 1 800 |
| 176 | Potassium | 1 test | 1 000 |
| 177 | Total calcium (Ca) | 1 test | 1 500 |
| 178 | Acid-base state (ABS) of blood (Blood gases) | 1 test | 5 400 |
| 179 | Magnesium (Mg) | 1 test | 1 600 |
| 180 | Copper (Cu) | 1 test | 1 250 |
| 181 | Sodium | 1 test | 1 500 |
| 182 | Organic phosphorus (P) | 1 test | 1 700 |
| 183 | Chlorine | 1 test | 1 500 |
| 184 | Electrolytes (potassium, sodium, ionized calcium, chlorine) in blood serum | 1 test | 4 500 |
| 185 | Acid-base state of blood, on a portable analyzer of gases, electrolytes and blood metabolites | 1 test | 10 000 |
| Hematological tests |
| 186 | LE-phenomenon (LE - cells, lupus cells) | 1 test | 3 000 |
| 187 | Blood test for malarial plasmodium using the “thin smear” and “thick smear” method | 1 test | 1 250 |
| 188 | CBC+DIFF | 1 test | 2 200 |
| 189 | CBC (short) (without WBC) | 1 test | 1 200 |
| 190 | Reticulocyte count | 1 test | 1 200 |
| 191 | Thrombocyte count according to Fonio | 1 test | 1 200 |
| Immune status |
| 192 | Indicators of cellular immunity (L/cytes; T-l/cytes-CD3+; T-helper cells-CD3.4+; T-cytotoxic - CD3.8+; B-l/cytes CD3-.19+; Natural killer cells - CD3 -,16,56+) | 1 test | 19 000 |
| 193 | Phagocytosis (oxygen-independent) | 1 test | 10 500 |
| Immunology research |
| Vitamins |
| 194 | Vitamin D total, 25-OH-VitD | 1 test | 7 300 |
| 195 | Vitamin D3, 25-OH-VitD3 | 1 test | 6 800 |
| 196 | Vitamin B12, Cyanocobalamin | 1 test | 4 000 |
| 197 | Active Vitamin B12, Holotranscobalamin | 1 test | 6 400 |
| 198 | Folic acid (Folate) | 1 test | 3 600 |
| Gastropanel BIOHIT |
| 199 | Immunological characteristics of the gastric mucosa (Gastropanel: pepsinogen I, pepsinogen II, gastrin-17B, gastrin-17S, Anti-Heli | 1 test | 23 000 |
| Hormones of the pituitary-adrenal system in the blood |
| 200 | Adrenocorticotropic hormone (ACTH) | 1 test | 4 800 |
| 201 | Aldosterone | 1 test | 6 800 |
| 202 | Growth hormone (Somatotropic hormone, hGH) | 1 test | 8 000 |
| 203 | Dehydroepiandrosterone sulfate (DHEA-s) | 1 test | 5 000 |
| 204 | Cortisol | 1 test | 4 000 |
| 205 | Catecholamines (adrenaline, noradrenaline, dopamine) in blood plasma by ELISA | 1 test | 23 000 |
| 206 | Melatonin in blood serum by ELISA method, quantitative determination | 1 test | 14 500 |
| Hormones of the pituitary-adrenal system in the urine |
| 207 | Adrenaline (epinephrine) in blood serum by ELISA method, quantitative determination | 1 test | 14 500 |
| 208 | Dopamine in blood serum by ELISA method, quantitative determination | 1 test | 14 500 |
| 209 | Noradrenaline (norepinephrine) in blood serum by ELISA method, quantitative determination | 1 test | 14 500 |
| 210 | Vanillyl mandelic acid in daily urine (VMA, 24h urine) | 1 test | 5 500 |
| 211 | Homovanillic acid in daily urine (HVA, 24h urine) | 1 test | 5 500 |
| 212 | Cortisol in daily urine (Cortisol, 24h urine) | | 4 900 |
| Pancreatic hormones |
| 213 | Insulin | 1 test | 4 500 |
| 214 | Binding peptide (C-Peptide) | 1 test | 4 800 |
| Reproductive system hormones |
| 215 | Anti-Mullerian hormone, AMH, MIS | 1 test | 7 500 |
| 216 | Sex hormone binding globulin (SHBG) | 1 test | 5 000 |
| 217 | Luteinizing hormone (LH) | 1 test | 3 500 |
| 218 | Progesterone | 1 test | 3 500 |
| 219 | Prolactin | 1 test | 3 500 |
| 220 | Testosterone | 1 test | 4 500 |
| 221 | Follicle stimulating hormone (FSH) | 1 test | 3 200 |
| 222 | Estradiol | 1 test | 3 100 |
| Thyroid hormones |
| 223 | Antibodies to thyroglobulin (Anti-Tg) | 1 test | 3 500 |
| 224 | Antibodies to thyroid peroxidase (Anti-TPO) | 1 test | 3 900 |
| 225 | Thyroglobulin (Tg) | 1 test | 4 200 |
| 226 | Thyroid stimulating hormone (TSH) | 1 test | 3 500 |
| 227 | Total thyroxine (total T4) | 1 test | 3 000 |
| 228 | Free thyroxine (FT4) | 1 test | 3 200 |
| 229 | Total triiodothyronine (total T3) | 1 test | 3 650 |
| 230 | Free triiodothyronine (FT3) | 1 test | 3 600 |
| Autoimmune pathology diagnostics (EIA, ECLIA) |
| 231 | Antimitochondrial antibodies M2 subtype (AMA-M2) | 1 test | 7 300 |
| 232 | Antineutrophil cytoplasmic antibodies screening (ANCA-screen) | 1 test | 7 500 |
| 233 | Antinuclear antibodies screening (ANA screen) | 1 test | 6 800 |
| 234 | Antinuclear antibodies screening (ANA-Detect) | 1 test | 6 800 |
| 235 | Antibodies to GBM in blood serum by ELISA method | 1 test | 8 300 |
| 236 | Antibodies to beta-2-glycoprotein I (Anti-ß-2 Glycoprotein) | 1 test | 6 700 |
| 237 | Antibodies to double-stranded DNA (a-dsDNA) | 1 test | 6 800 |
| 238 | Antibodies to single-stranded DNA (a-ssDNA) | 1 test | 6 800 |
| 239 | Antibodies to gastric parietal cells (a-Parietal cell IgG) | 1 test | 6 800 |
| 240 | Antibodies to tissue transglutaminase screening (a-tTG IgA,G) | 1 test | 6 800 |
| 241 | Antibodies to elastase (Anti-Elastase) | 1 test | 6 800 |
| 242 | Class A antibodies to Saccharomyces cerevisiae (ASCA IgA) | 1 test | 6 800 |
| 243 | Class G antibodies to Saccharomyces cerevisiae (ASCA IgG) | 1 test | 6 800 |
| 244 | Class G antibodies to histones (a-Histone IgG) | 1 test | 7 500 |
| 245 | Class G antibodies to cardiolipin (A-Cardiolipin IgG) | 1 test | 7 500 |
| 246 | Class G antibodies to modified citrullinated vimentin (A-MCV IgG) | 1 test | 8 200 |
| 247 | Class G antiphospholipid antibodies (AFL IgG) | 1 test | 7 400 |
| 248 | Class M antibodies to cardiolipin (A-Cardiolipin IgM) | 1 test | 7 400 |
| 249 | Class M antiphospholipid antibodies (AFL IgM) | 1 test | 6 800 |
| 250 | Anti-Prothrombin screening | 1 test | 6 800 |
| 251 | Antibodies to insulin (A-insulin) | 1 test | 7 500 |
| 252 | Total antibodies class A, M, G to cardiolipin, screening (A-Cardiolipin total) | 1 test | 6 800 |
| 253 | Extractable nuclear antibodies, extensive assay (ENA combi) | 1 test | 21 800 |
| 254 | Antineutrophil cytoplasmic antibodies, extensive assay (ANCA-combi) | 1 test | 33 800 |
| 255 | Antinuclear antibodies, extensive analysis (ANA combi) | 1 test | 24 500 |
| 256 | Antisperm antibodies (ASA) | 1 test | 11 000 |
| 257 | IgG antibodies to cyclic citrullinated peptide (a-CCP) | 1 test | 15 200 |
| 258 | Antibodies to insulin in blood serum by ELISA method, quantification | 1 test | 5 000 |
| 259 | Extractable nuclear antibodies, screening (ENA screen) | 1 test | 6 500 |
| 260 | "ANA pro" for semi-quantitative determination of IgG antibodies to nuclear and cytoplasmic antigens in human serum and plasma | 1 test | 20 000 |
| 261 | "ANCA Dot" for the qualitative determination of IgG antibodies to myeloperoxidase (MPO), proteinase 3 (PR-3) and glomerular basement membrane (GBM) in human serum and plasma | 1 test | 23 000 |
| 262 | "ANA 12 LINE" for the qualitative determination of IgG antibodies to nuclear and cytoplasmic antigens in human serum and plasma | 1 test | 25 000 |
| 263 | Gliadin – IgG Reagent kit for quantitative enzyme immunoassay (ELISA) for the determination of IgG antibodies to gliadin in blood serum | 1 test | 10 500 |
| 264 | Gliadin – IgA Reagent kit for enzyme immunoassay (ELISA) for the determination of IgA antibodies to gliadin in blood serum | 1 test | 10 500 |
| Autoimmune pathology diagnostics (LIA tests) |
| 265 | Antibodies in autoimmune vasculitis IMTEC-Vasculitis-LIA (IgG to PR3, MPO and GBM) | 1 test | 26 200 |
| 266 | Antibodies in autoimmune liver diseases IMTEC-Liver-LIA S (IgG to AMA M2, Sp100, LKM1, gp210, LC1 and SLA) | 1 test | 13 500 |
| 267 | Antinuclear antibodies ANA-LIA (IgG to nucleosomes, dsDNA, histones, SmD1, U1-snRNP, SS-A/Ro60kD, SS-A/Ro52kD, SS-B/La, Scl70, CENP-B, Jo1, P0) | 1 test | 6 200 |
| 268 | Antinuclear antibodies ANA-LIA MAXX: IgG to nucleosomes, dsDNA, histones, SmD1, PCNA, P0, SS-A/Ro60 and 52kD, SS–B/La, CENP-B, Scl-70, U1-snRNP, AMA M2, Jo-1, PM-Scl, Mi-2(β), Ku | 1 test | 27 600 |
| 269 | Antibodies in autoimmune myositis IMTEC-Myositis-LIA (IgG to Jo1, Mi2, PM-Scl, U1-snRNP and Ku) | 1 test | 14 100 |
| 270 | Antibodies for celiac disease IMTEC-Celiac Disease-LIA S (IgA and IgG to gliadin, tissue transglutaminase) | 1 test | 6 000 |
| 271 | Antibodies in gastrointestinal diseases Gastro-LIA (IgA and IgG to gliadin, tTG, mannan, PCA, Castle factor) | 1 test | 18 800 |
| Autoimmune pathology diagnostics using indirect immunofluorescence (inDIF) |
| 272 | Antikeratin antibodies (AKA) by indirect immunofluorescence (inDIF) | 1 test | 8 250 |
| 273 | Antineutrophil cytoplasmic antibodies (ANCA) by indirect immunofluorescence (inDIF) | 1 test | 6 050 |
| 274 | Antinuclear factor on the HEp-2 cell line (ANF) by indirect immunofluorescence (inDIF) | 1 test | 8 250 |
| 275 | Antibodies to native DNA (a-nDNA) by indirect immunofluorescence (inDIF) | 1 test | 8 250 |
| 276 | Autoantibodies by the method (nRIF) on a triple substrate (LKM-1, Antibodies to gastric parietal cells, to smooth muscles (F-actin), ANF on the HEp-2 cell line, AMA-M1.9) | 1 test | 8 250 |
| Immune status |
| 277 | Alpha interferon in the blood | 1 test | 8 000 |
| 278 | Gamma interferon in the blood | 1 test | 8 000 |
| 279 | Secretory immunoglobulin A in blood serum (sIgA) | 1 test | 4 800 |
| 280 | Total Immunoglobulin E (total IgE) | 1 test | 5 300 |
| 281 | Immunophenotyping of HLA B27 in blood using flow cytometry | 1 test | 20 000 |
| 282 | Interleukin-10 | 1 test | 6 500 |
| 283 | Interleukin-2 | 1 test | 8 000 |
| 284 | Interleukin-6 | 1 test | 8 000 |
| 285 | Interleukin-8 | 1 test | 6 500 |
| 286 | Interleukin - 13 (IL-13) in serum and blood plasma | 1 test | 17 500 |
| 287 | Interleukin - 3 (IL-3) in serum and blood plasma | 1 test | 31 000 |
| 288 | Interleukin - 5 (IL-5) in serum and blood plasma | 1 test | 17 500 |
| 289 | Interleukin - 1 beta (IL-1-beta, IL-1-β) in human biological fluids and culture media by ELISA method, quantitation | 1 test | 8 800 |
| 290 | Interleukin - 13 (IL-13, IL-13) in blood serum by ELISA method, quantitation | 1 test | 9 500 |
| 291 | Interleukin - 18 (IL-18, IL-18) in blood serum by ELISA method, quantitation | 1 test | 7 600 |
| 292 | Interleukin - 3 (IL-3, IL-3) in blood serum by ELISA method, quantitation | 1 test | 9 500 |
| 293 | Interleukin - 4 (IL-4, IL-4) in blood serum by ELISA method, quantitation | 1 test | 7 800 |
| 294 | Interleukin - 5 (IL-5, IL-5) in blood serum by ELISA method, quantitation | 1 test | 9 500 |
| 295 | Eosinophil cationic protein (ECP) | 1 test | 9 000 |
| 296 | Tryptase | 1 test | 7 800 |
| Serological markers of coronavirus infection SARS-CoV-2 (COVID-19, 2019-nCoV) |
| 297 | IgM antibodies to SARS-CoV-2 (qualitative) | 1 test | 4 300 |
| 298 | IgG antibodies to SARS-CoV-2 (qualitative) | 1 test | 4 350 |
| 299 | nCoV antibodies - Nab (post-vaccination, quantitative) | 1 test | 5 000 |
| 300 | Immunoglobulin G to SARS-CoV-2 (quantitative) | 1 test | 5 000 |
| 301 | Immunoglobulin M to SARS-CoV-2 (quantitative) | 1 test | 6 000 |
| 302 | IgG/IgM antibodies to SARS-CoV-2 (Rapid test) (qualitative) | 1 test | 6 500 |
| 303 | Sars-CoV-2 specific antigen (rapid test) (qualitative) | 1 test | 5 400 |
| Drug monitoring |
| 304 | Tacrolimus in blood serum by immunochemiluminescence | 1 test | 9 600 |
| Markers of sepsis |
| 305 | Procalcitonin, PCT (quantitation by enzyme immunoassay) | 1 test | 10 000 |
| 306 | Procalcitonin, PCT (quantitation by immunofluorescence method) | 1 test | 8 700 |
| Bone metabolism |
| 307 | Osteocalcin (N-MID Osteocalcin) | 1 test | 6 000 |
| 308 | Parathyroid hormone (PTH) | 1 test | 5 700 |
| 309 | Pyrilinks-D (DPD) | 1 test | 3 600 |
| Tumor markers |
| 310 | Alpha 1-fetoprotein (AFP) | 1 test | 3 600 |
| 311 | Squamous cell carcinoma antigen (SCC-Ag) | 1 test | 3 900 |
| 312 | Calcitonin | 1 test | 8 500 |
| 313 | Neuron - specific enolase (NSE, NSE) in blood serum by immunochemiluminescence | 1 test | 6 000 |
| 314 | Progastrin releasing peptide (ProGRP) | 1 test | 5 300 |
| 315 | Prostate-specific antigen total (PSA total, PSA total) | 1 test | 3 000 |
| 316 | Prostate-specific antigen free (PSA free) | 1 test | 3 500 |
| 317 | Carcinoembryonic antigen (CEA, CEA) | 1 test | 3 700 |
| 318 | Cancer antigen 72-4 (CA 72-4) | 1 test | 6 500 |
| 319 | Cancer antigen 125 (CA 125) | 1 test | 4 200 |
| 320 | Cancer antigen 15-3 (CA 15-3) | 1 test | 3 900 |
| 321 | Cancer antigen 19-9 (CA 19-9) | 1 test | 4 200 |
| 322 | Cancer antigen 242 (CA 242) | 1 test | 8 200 |
| 323 | Tumor necrosis factor-alpha (TNF-α, α-TNF) | 1 test | 5 500 |
| 324 | Cytokeratin fragment 19 (Cyfra21-1) | 1 test | 5 500 |
| 325 | Human chorionic gonadotropin intact + beta subunit (HCG+beta) | 1 test | 5 500 |
| 326 | Total human chorionic gonadotropin in urine (HCG urine) | 1 test | 4 500 |
| 327 | Total human chorionic gonadotropin (HCG) | 1 test | 2 350 |
| 328 | Human epididymal protein 4 (HE4) | 1 test | 6 500 |
| Other tests |
| 329 | Homocysteine (Hcy-SH) | 1 test | 6 500 |
| 330 | Erythropoietin (EPO) | 1 test | 4 300 |
| 331 | Pancreatic elastase content in feces | 1 test | 15 000 |
| Serological markers of brucellosis |
| 332 | Class A antibodies to the causative agent of brucellosis | 1 test | 4 000 |
| 333 | Class G antibodies to the causative agent of brucellosis | 1 test | 4 000 |
| 334 | Class M antibodies to the causative agent of brucellosis | 1 test | 4 000 |
| Serological markers of viral hepatitis D |
| 335 | Total class M, G antibodies to hepatitis D virus (a-HDV total) | 1 test | 3 000 |
| Serological markers of viral hepatitis A |
| 336 | Class M antibodies to hepatitis A virus (a-HAV IgM) | 1 test | 2 400 |
| Serological markers of viral hepatitis B |
| 337 | Hepatitis B virus "e" antigen (HBeAg) | 1 test | 2 550 |
| 338 | Class G antibodies to the “e” antigen of the hepatitis B virus (a-HBeAg IgG) | 1 test | 2 300 |
| 339 | Antibodies class G to the nuclear antigen of the hepatitis B virus (a-HBcAg IgG) | 1 test | 2 700 |
| 340 | Antibodies class M to the nuclear antigen of the hepatitis B virus (a-HBcAg IgM) | 1 test | 2 600 |
| 341 | Hepatitis B surface antigen (HBsAg, Australian antigen) | 1 test | 2 400 |
| 342 | Total antibodies class M, G to the “e” antigen of the hepatitis B virus (a-HBeAg total) | 1 test | 2 600 |
| 343 | Total antibodies class M, G to the surface antigen of the hepatitis B virus (a-HBsAg total) | 1 test | 2 900 |
| 344 | Total antibodies class M, G to the nuclear antigen of the hepatitis B virus (a-HBcAg total) | 1 test | 3 200 |
| 345 | НBsAg, Rapid test (Hepatitis B surface antigen, qualitation) | 1 test | 1 800 |
| Serological markers of viral hepatitis C |
| 346 | Hepatitis C virus antigen (HCV Ag) | 1 test | 8 500 |
| 347 | Antibodies class M to hepatitis C virus (HCV IgM) | 1 test | 3 500 |
| 348 | Total antibodies class M, G to hepatitis C virus (a-HCV total) | 1 test | 2 880 |
| 349 | a-HCV, Rapid test (Specific antibodies to hepatitis C virus, qualitation) | 1 test | 1 900 |
| Serological markers of HIV infection |
| 350 | HIV p24 antigen and antibodies to human immunodeficiency virus types 1, 2 (HIV-1/2, HIV-1/2) | 1 test | 3 000 |
| 351 | Immunochromatic rapid test of the third generation for the determination of antibodies to human immunodeficiency virus types 1 and 2 (a-HIV-1/2) | 1 test | 2 000 |
| 352 | Express test for determining the free antigen HIV-1 p24 antibodies and antibodies to human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) | 1 test | 3 200 |
| 353 | ELISA for the presence of antibodies to the human immunodeficiency virus (HIV, AIDS center) | 1 test | 2 500 |
| Serological markers of herpes infection |
| 354 | Class G antibodies to herpes simplex virus type 8 (HSV-8-IgG) | 1 test | 2 700 |
| 355 | Class G antibodies to herpes simplex virus types 1 and 2 (HSV-1,2-IgG) | 1 test | 3 000 |
| 356 | Class G antibodies to herpes simplex virus type 1 (HSV-1-IgG) | 1 test | 2 150 |
| 357 | Class G antibodies to herpes simplex virus type 2 (HSV-2-IgG) | 1 test | 2 800 |
| 358 | Antibodies class G to herpes simplex virus type 6, (HHV-6-IgG) | 1 test | 3 000 |
| 359 | Class M antibodies to herpes simplex virus types 1 and 2 (HSV-1,2-IgM) | 1 test | 2 800 |
| 360 | Class M antibodies to herpes simplex virus type 2 (HSV-2-IgM) | 1 test | 3 300 |
| 361 | Antibodies class M to herpes simplex virus type 1 (HSV-1-IgM) | 1 test | 2 500 |
| 362 | Avidity index of class G antibodies to herpes simplex virus types 1 and 2 (HSV–1,2-IgG–Avidity) | 1 test | 3 100 |
| 363 | Avidity index of class G antibodies to herpes simplex virus type 2 (HSV–2-IgG–Avidity) | 1 test | 3 100 |
| Serological markers of infectious mononucleosis |
| 364 | Class G antibodies to Epstein-Barr virus early antigen (EBV-EA IgG) | 1 test | 3 200 |
| 365 | Class G antibodies to Epstein-Barr virus nuclear antigen (EBV-NA IgG) | 1 test | 3 200 |
| 366 | Class G antibodies to Epstein-Barr virus capsid antigen (EBV-VCA IgG) | 1 test | 3 200 |
| 367 | Antibodies class M to Epstein-Barr virus capsid antigen (EBV-VCA IgM) | 1 test | 3 200 |
| 368 | Index of avidity of class G antibodies to the capsid antigen of the Epstein-Barr virus (EBV-VCA IgG-Avidity) | 1 test | 3 500 |
| Serological markers of rubella |
| 369 | Class G antibodies to rubella virus (Rubella IgG) | 1 test | 2 600 |
| 370 | Class M antibodies to rubella virus (Rubella IgM) | 1 test | 2 800 |
| 371 | Avidity index of class G antibodies to rubella virus (Rubella IgG-Avidity) | 1 test | 3 200 |
| Serological markers of listeriosis |
| 372 | Class G antibodies to Listeria monocytogenes | 1 test | 2 200 |
| Serological markers of cytomegalovirus infection |
| 373 | Antibodies of class G and M to the immediate early protein of cytomegalovirus (CMV-IEA-IgG/M) | 1 test | 3 600 |
| 374 | Antibodies class G to cytomegalovirus (CMV IgG) | 1 test | 3 700 |
| 375 | Antibodies class M to cytomegalovirus (CMV IgM) | 1 test | 3 600 |
| 376 | Index of avidity of class G antibodies to cytomegalovirus (CMV-IgG-Avidity) | 1 test | 3 500 |
| Serological markers. Antibodies to protozoa, parasites and fungi |
| 377 | Class G antibodies to fungi of the genus Candida albicans (Candida albicans IgG) | 1 test | 3 500 |
| 378 | Class A antibodies to Trichomonas (Trichomonas vaginalis IgA) | 1 test | 3 500 |
| 379 | Class G antibodies to Ascaris antigens (Ascaris lumbricoides IgG) | 1 test | 3 500 |
| 380 | Class G antibodies to Aspergillus antigens (Aspergillus IgG) | 1 test | 3 500 |
| 381 | Class G antibodies to Opisthorchis antigens (a-Opistorhide IgG) | 1 test | 3 500 |
| 382 | Class G antibodies to Toxocara antigens (a-Toxocara IgG) | 1 test | 3 500 |
| 383 | Class G antibodies to Trichinella antigens (a-Trichinella IgG) | 1 test | 3 500 |
| 384 | Class G antibodies to Echinococcus unilocular antigens (a-Echinococcus IgG) | 1 test | 3 500 |
| 385 | Class G antibodies to Toxoplasma (Toxoplasma gondii IgG) | 1 test | 3 500 |
| 386 | Class G antibodies to Trichomonas (Trichomonas vaginalis IgG) | 1 test | 3 500 |
| 387 | Class A antibodies to Toxoplasma (Toxoplasma gondii IgA) | 1 test | 3 500 |
| 388 | Class M antibodies to Toxoplasma (Toxoplasma gondii IgM) | 1 test | 3 500 |
| 389 | Avidity index of class G antibodies to Toxoplasma (Toxoplasma gondii IgG–Avidity) | 1 test | 2 900 |
| 390 | Specific circulating immunocomplexes (CICs) containing opisthorchis antigens | 1 test | 3 800 |
| 391 | Total antibodies of class A, M, G to lamblia (a-Lamblia total) | 1 test | 3 000 |
| Serological markers. Bacterial antibodies |
| 392 | Class A antibodies to mycoplasma (Mycoplasma hominis IgA) | 1 test | 3 000 |
| 393 | Class A antibodies to ureaplasma (Ureaplasma urealyticum IgA) | 1 test | 3 000 |
| 394 | Class G antibodies to ureaplasma (Ureaplasma urealyticum IgG) | 1 test | 3 000 |
| 395 | Class G antibodies to Helycobacter pylori | 1 test | 3 465 |
| 396 | Class G antibodies to Chlamydia trachomatis heat shock protein (HSP60), diagnosis of early infection | 1 test | 2 200 |
| 397 | Class G antibodies to major outer membrane protein (MOMP) and plasmid protein pgp3 of Chlamydia trachomatis | 1 test | 2 600 |
| 398 | Class G antibodies to mycoplasma (Mycoplasma hominis IgG) | 1 test | 3 000 |
| 399 | Class G antibodies to chlamydia (Chlamydia trachomatis IgG) | 1 test | 3 000 |
| 400 | Class M antibodies to chlamydia (Chlamydia trachomatis IgM) | 1 test | 3 000 |
| 401 | Class A antibodies to chlamydia (Chlamydia trachomatis IgA) | 1 test | 3 000 |
| 402 | Total antibodies class A, M, G to the Cag antigen of Helycobacter pylori | 1 test | 3 000 |
| 403 | Total antibodies class A, M, G to Mycobacterium tuberculosis (a-Mycobacterium Tuberculosis) | 1 test | 3 200 |
| 404 | Total antibodies class A, M, G to syphilis (Treponema pallidum total) | 1 test | 3 200 |
| Specific blood proteins |
| 405 | N-terminal pro-brain B-type natriuretic peptide (NT-pro BNP) | 1 test | 16 500 |
| 406 | Troponin I (TNI), quantitation | 1 test | 7 400 |
| 407 | Troponin I high sensitivity (TNI), quantitation | 1 test | 8 700 |
| 408 | Rapid test for the qualitation of Troponin I (TNI) and myoglobin | 1 test | 2 350 |
| 409 | Brain natriuretic peptide (BNP) | 1 test | 20 000 |
| |
| 410 | Neutrophil gelatinase-associated lipocalin, NGAL | 1 test | 6 400 |
| Microbiological testings |
| Bacteriological testings |
| 411 | Bacteriological examination of autopsy material | 1 test | 6 500 |
| 412 | Bacteriological examination of biomaterial from the nose for staphylococcus | 1 test | 5 500 |
| 413 | Bacteriological examination of biomaterial for anaerobes | 1 test | 5 700 |
| 414 | Bacteriological examination of biomaterial for yersiniosis | 1 test | 5 500 |
| 415 | Bacteriological examination of biomaterial for meningococcus | 1 test | 7 000 |
| 416 | Bacteriological examination of biomaterial for microflora | 1 test | 9 000 |
| 417 | Bacteriological examination of biomaterial for the presence of the causative agent of diphtheria | 1 test | 6 500 |
| 418 | Bacteriological examination of biomaterial for the presence of fungi with identification of their species | 1 test | 6 300 |
| 419 | Bacteriological examination of stool for cholera (form 30) | 1 test | 6 500 |
| 420 | Bacteriological blood test for sterility using a bacteriological analyzer | 1 test | 8 400 |
| 421 | Bacteriological test for group B streptococcus (GBS) | 1 test | 14 500 |
| 422 | Taking biomaterial for microbiological research | 1 test | 1 200 |
| 423 | Test for intestinal dysbiosis | 1 test | 14 000 |
| 424 | Bacteriological examination of feces for pathogenic and opportunistic intestinal microflora with sensitivity determination | 1 test | 5 200 |
| 425 | Identification of a pure culture of a microorganism using mass spectrometry | 1 test | 2 100 |
| 426 | Bacteriological examination of biomaterial for meningococcus PASTOREX MENINGITIS | 1 test | 22 000 |
| 427 | Bacteriological examination of genital secretions using the Genital SYSTEM method | 1 test | 15 000 |
| 428 | Gene-Xpert Determination of M. tuberculosis and rifampicin resistance | 1 test | 37 000 |
| Sanitary and bacteriological testings |
| 429 | Bacteriological air testing (1 room) | 1 test | 2 100 |
| 430 | Bacteriological examination of liquid dosage forms and material for sterility (10 samples) | 1 test | 3 300 |
| 431 | Bacteriological testing swabs from environmental objects for coliform bacteria (coliforms), pathogenic intestinal flora, golden staff | 1 test | 1 500 |
| Sputum examinations |
| 432 | Microscopic examination of biomaterial for the presence of acid-fast bacteria (AFB) for suspected tuberculosis | 1 test | 2 400 |
| Parasitological examination of stool |
| 433 | Examination of stool for helminth eggs using a fecal parasite concentrator | 1 test | 2 500 |
| 434 | Examination of stool for protozoa and helminth eggs | 1 test | 1 600 |
| Serological diagnosis of syphilis |
| 435 | Microreaction | 1 test | 1 250 |
| 436 | Wasserman reaction (RW) | 1 test | 3 700 |
| 437 | Syphilis, Rapid test (Specific antibodies to Treponema pallidum, qualitative determination) | 1 test | 3 400 |
| Molecular biological research (PCR) |
| PCR based bacterial infections diagnostics |
| 438 | Brucella DNA (DNA Brucella species) | 1 test | 5 000 |
| 439 | DNA of the causative agent of respiratory mycoplasmosis/chlamydia (Mycoplasma pneumoniae/Chlamydophila pneumoniae DNA) | 1 test | 6 200 |
| 440 | Mycobacterium tuberculosis DNA (Mucobacterium tuberculosis DNA) | 1 test | 3 600 |
| 441 | Toxoplasma gondii DNA | 1 test | 3 500 |
| PCR based viral hepatitis diagnostics |
| 442 | Hepatitis C virus genotyping: 1a, 1b, 2, 3a, 4b genotypes (HCV Genotype, HCV Genotyping/Subtyping) Genotyping/Subtyping) | 1 test | 12 600 |
| 443 | Hepatitis B virus DNA, qualitaion (HBV DNA Qualitative) | 1 test | 8 500 |
| 444 | Hepatitis B virus DNA, quantitation (HBV DNA viral load, HBV DNA Quant.) | 1 test | 11 800 |
| 445 | Hepatitis D virus RNA, qualitation (HDV RNA Qualitative) | 1 test | 9 500 |
| 446 | Hepatitis C virus RNA quantitation (HCV RNA viral load, HCV RNA Quant.) | 1 test | 13 200 |
| 447 | Hepatitis C virus RNA, qualitation (HCV RNA, RNA HCV Qualitative) | 1 test | 9 300 |
| PCR based viral infections diagnostics |
| 448 | PCR based diagnostics of the COVID-19 virus | 1 test | 7 500 |
| 449 | DNA cytomegalovirus (DNA Cytomegalovirus Quant), quantitation) | 1 test | 10 000 |
| 450 | DNA of Gardnerella and others (Florocenosis/bacterial vaginosis) quantitation | 1 test | 4 700 |
| 451 | Human papillomavirus DNA of high carcinogenic risk, screening (HPV DNA, high-risk HPV DNA) | 1 test | 10 500 |
| 452 | Varicella-Zoster virus DNA (VZV DNA, DNA Varicella-Zoster virus, DNA VZV) | 1 test | 2 500 |
| 453 | DNA Rubella virus (DNA Rubella virus) | 1 test | 2 600 |
| 454 | Human papillomavirus DNA 16/18 types (HPV DNA 16/18, DNA НРV 16/18) | 1 test | 6 000 |
| 455 | DNA of herpes simplex virus types 1 and 2 (DNA HSV 1, 2) | 1 test | 6 000 |
| 456 | Epstein-Barr virus DNA (DNA EBV Qualitative), qualitation | 1 test | 3 000 |
| 457 | Epstein-Barr virus DNA (EBV DNA, DNA EBV Quant), quantitation) | 1 test | 6 000 |
| 458 | DNA of ARVI pathogens | 1 test | 6 500 |
| 459 | DNA cytomegalovirus (DNA Cytomegalovirus) | 1 test | 7 500 |
| 460 | Detection of the DNA of the causative agent of pertussis | 1 test | 5 200 |
| 461 | Detection of the DNA of the causative agent of pneumocysosis | 1 test | 5 000 |
| 462 | Detection of human metapneumovirus RNA and human parainfluenza virus type 2 RNA | 1 test | 13 000 |
| PCR based urogenital infections diagnostics |
| 463 | DNA of ureaplasma and mycoplasma (Florocenosis/ureaplasma, mycoplasma) (quantitation) | 1 test | 4 600 |
| 464 | Candida DNA (Florocenosis/Candida) (quantitation) | 1 test | 4 500 |
| 465 | Candida albicans DNA | 1 test | 3 700 |
| 466 | Chlamydia trachomatis DNA | 1 test | 3 700 |
| 467 | Gardnerella vaginalis DNA | 1 test | 3 700 |
| 468 | Mycoplasma genitalum DNA | 1 test | 3 700 |
| 469 | Mycoplasma hominis DNA | 1 test | 3 700 |
| 470 | Neisseria gonorrhoeae DNA | 1 test | 3 700 |
| 471 | Trichomonas vaginalis DNA | 1 test | 3 700 |
| 472 | Ureaplasma species DNA | 1 test | 3 700 |
| PCR based other infections diagnostics |
| 473 | DNA of helminthiasis pathogens (Ascaris lumbricoides, Enterobius vermicularis, Opisthorchis felineus, Taenia solium, Diphyllobothrium latum) | 1 test | 7 550 |
| 474 | DNA from pathogens of protozoal infections (Lamblia Intestinalis Giardia, Blastocystis hominis, Dientamoeba fragilis, Isospora belli, Cryptosporidium parvum, Entamoeba histolytica) | 1 test | 7 550 |
| General clinical studies |
| General clinical stool examinations |
| 475 | Examination of feces for occult blood | 1 test | 2 200 |
| 476 | Test for Helicobacter pylori antigen (qualitation, rapid test) | 1 test | 4 200 |
| 477 | Calprotectin (qualitation, rapid test) | 1 test | 6 500 |
| 478 | Calprotectin (quantitation by enzyme immunoassay) | 1 test | 10 000 |
| 479 | Coprogram | 1 test | 3 000 |
| General clinical urine tests |
| 480 | Protein in daily urine | 1 test | 1 700 |
| 481 | Urinalysis according to Nechiporenko | 1 test | 2 000 |
| 482 | Daily urinу analysis according to Zimnitsky | 1 test | 2 000 |
| 483 | Microalbumin (MAU) in a single portion of urine (semi-quantitative determination) | 1 test | 1 000 |
| 484 | General sputum analysis | 1 test | 2 000 |
| 485 | General urinalysis (UCA) | 1 test | 1 400 |
| 486 | Rhinocytogram (cellular composition) | 1 test | 2 200 |
| 487 | Three-glass urine sample | 1 test | 1 300 |
| Сlinical examinations of urethral and vaginal discharge |
| 488 | Microscopic examination of urethral discharge (urethral smear) | 1 test | 2 300 |
| 489 | Microscopic examination of prostate secretion (prostate gland) | 1 test | 2 300 |
| 490 | Determining the degree of purity of a gynecological smear | 1 test | 3 000 |
| 491 | Spermogram with determination of sperm morphology | 1 test | 8 500 |
| 492 | MAR test | 1 test | 7 500 |
| Сlinical examinations of other biomaterial |
| 493 | Biomaterial examination for the genus Demodex (Demodex) | 1 test | 2 000 |
| 494 | Biomaterial examination for the pathogenic fungi | 1 test | 1 700 |
| 495 | Clinical examination of cerebrospinal fluid (CSF, cerebrospinal fluid) | 1 test | 1 200 |
| 496 | Clinical examination of duodenal contents (bile) | 1 test | 2 800 |
| 497 | Clinical examination of serous cavities fluids and cysts (exudate, transudate) | 1 test | 1 300 |
| 498 | Microscopic examination of a smear stained according to Romanovsky | 1 test | 1 900 |
| 499 | Microscopic examination of skin scrapings for the scabies mites. | 1 test | 2 000 |
| Genomic laboratory services |
| 500 | Molecular genetic analysis of mutations, chimeric transcripts and copy number variants in 52 key genes connected with canceration, pan | 1 test | 450 000 |
| 501 | Molecular genetic analysis of mutations, chimeric transcripts and copy number variants in 69 key genes connected with the development of myeloid disorders | 1 test | 480 000 |
| 502 | Molecular genetic diagnosis of V600E mutations in the BRAF gene from tumor cells enclosed in paraffin sections | 1 test | 29 000 |
| 503 | Molecular genetic diagnosis of mutations in the ALK gene from tumor cells enclosed in paraffin sections | 1 test | 45 000 |
| 504 | Whole exome sequencing of human DNA to search for a presumably hereditary disease with interpretation of the results | 1 test | 1 100 000 |
| 505 | Mutations in HLA CLASS II genes - DQ2, DQ8, DQA1*05 in celiac disease using real-time PCR | 1 test | 90 000 |
| 506 | FISH diagnostics of bone marrow cells to identify the chimeric gene BCR/ABL t(9;22), in CML and ALLrh+ | 1 test | 50 050 |
| 507 | FISH diagnosis of bladder cancer to detect aneuploidy of chromosomes 3, 7, 17 and deletion of the 9p21 locus | 1 test | 74 000 |
| 508 | FISH diagnosis of numerical chromosomal pathologies 13, 18, 21, X and Y in amniotic fluid | 1 test | 59 000 |
| 509 | Qualitation of the chimeric gene BCR/ABL-t(9;22) using real-time PCR | 1 test | 16 000 |
| 510 | Quantitative determination of the BCR/ABL-t(9;22) chimeric gene using real-time PCR | 1 test | 27 000 |
| 511 | Molecular genetic diagnosis using MLPA method of large deletions/duplications in the SMN1 and SMN2 genes associated with spinal muscular atrophy | 1 test | 70 500 |
| 512 | Minimal residual disease | 1 test | 27 000 |
| 513 | Mutation in the DMD gene in Duchenne muscular dystrophy using the MLPA method | 1 test | 70 500 |
| 514 | Standard cytogenetic research (karyotyping) of peripheral blood cells | 1 test | 30 000 |
| 515 | Quantitative and qualitative molecular genetic diagnosis of the chimeric gene BCR/ABL-t(9;22), determination of the type of BCR/ABL gene transcript in hemo | 1 test | 43 000 |
| 516 | Molecular genetic analysis (genotyping) of mutations in genes associated with the risk of arterial hypertension and diabetes mellitus 2 s | 1 test | 59 720 |
| 517 | Molecular genetic diagnosis of V617F mutations in the JAK2 gene in myeloproliferative diseases | 1 test | 27 000 |
| 518 | Molecular genetic assessing the ratios of human microorganisms (microbiome) | 1 test | 167 000 |
| 519 | Molecular genetic prenatal diagnosis of amniotic fluid cells for aneuploidy of chromosomes 13, 18, 21, X, Y | 1 test | 56 000 |
| 520 | Molecular genetic analysis (genotyping) of mutations in genes associated with changes in pharmacological response | 1 test | 59 720 |
| 521 | Molecular genetic analysis of mutations in 12 genes associated with epidermolysis bullosa | 1 test | 175 000 |
| 522 | Molecular genetic analysis of sensitivity to imatinib for patients with the Ph chromosome in CML and ALLPh+ | 1 test | 29 000 |
| 523 | Preimplantation molecular genetic screening of embryos for chromosomal pathologies on 24 chromosomes | 1 test | 110 000 |
| 524 | Molecular genetic diagnosis of polymorphism for susceptibility genes PNPLA3 and TM6SF2 in non-alcoholic steatohepatitis | 1 test | 14 200 |
| 525 | Mutations in the BRCA gene Oncomine Research Assay | 1 test | 319 000 |
| 526 | Mutations, chimeric transcripts and copy number variants in 161 genes associated with canceration, ONCOMINE Comprehensive ASSAY panel | 1 test | 440 000 |
| 527 | Genealogical origin by Y chromosome | 1 test | 78 500 |
| 528 | Mutations in the FLT3 gene (ITD, TKD - D835F) by molecular genetic method | 1 test | 32 000 |
| 529 | JAK2 gene mutations in exon 12 by MLPA method (fragment analysis) | 1 test | 45 000 |
| 530 | Mutation in the PIK3CA gene using a molecular genetic method | 1 test | 45 000 |
| 531 | Mutations in the CFTR gene in cystic fibrosis | 1 test | 71 500 |
| 532 | Individual sensitivity to warfarin | 1 test | 37 500 |
| 533 | Microdeletions (fragment analysis) using the MLPA method for delayed psychomotor development | 1 test | 70 500 |
| 534 | Genotyping in Amyotrophic Lateral Sclerosis | 1 test | 43 000 |
| 535 | Mutations in the KRAS gene | 1 test | 101 000 |
| 536 | Molecular genetic analysis for microsatellite instability (MSI) | 1 test | 114 000 |
| 537 | Fetal Rh factor in maternal blood | 1 test | 46 500 |
| 538 | Mutations in freely circulating tumor DNA | 1 test | 600 000 |
| 539 | Mutations in the NF1 gene in neurofibromatosis using the MLPA method | 1 test | 216 000 |
| 540 | Chimeric gene KIAA-BRAF, BRAF V600E by MLPA | 1 test | 90 000 |
| 541 | ERBB2 (HER2) gene amplification | 1 test | 80 000 |
| 542 | Non-invasive prenatal testing for the risk of aneuploidies (chromosomes 13,18,21) | 1 test | 150 000 |
| 543 | Determination of CD274 (PD-L1) gene amplification | 1 test | 88 000 |
| 544 | Detection of SMN1 and SMN2 gene mutations using PCR | 1 test | 6 500 |
| 545 | HPV genotyping by sequencing | 1 test | 60 000 |
| 546 | Gene sequencing for hereditary diseases using NGS (Next-Generation Sequencing) | 1 test | 420 000 |
| Gliomas diagnostics |
| 547 | Detection of aberrant methylation (MGMT) | 1 test | 45 500 |
| 548 | Detection of mutations in the IDH1 and IDH2 genes | 1 test | 45 500 |
| 549 | Detection of WNT and SHH pathway activation mutations | 1 test | 62 500 |
| 550 | Detection of mutations in the CDKN2A/2B genes | 1 test | 45 500 |
| 551 | Detection of mutations in the EGFR gene | 1 test | 45 500 |
| 552 | Detection of mutations in the ATRX gene | 1 test | 45 500 |
| 553 | Detection of mutations in the TP53 gene | 1 test | 45 500 |
| 554 | Detection of 1p/19q co-expression | 1 test | 45 500 |
| 555 | Detection of H3K27 mutation | 1 test | 105 000 |
| 556 | Detection of mutations in the MYCN gene | 1 test | 45 500 |
| 557 | Detection of RELA fusion mutation | 1 test | 91 500 |
| 558 | C19MC gene, miRNA profiling | 1 test | 35 500 |
| 559 | Detection of mutations in the VEGF gene
| 1 test | 42 000 |
| 560 | “Glioma” panel (Mutation status of tumor cells in gliomas | 1 test | 430 000 |
| 561 | Detection of mutations in the FGFR gene | 1 test | 60 000 |
